Sara Nik

Stock Analyst at HC Wainwright & Co.

(n/a)

# 4,912

Out of 5,147 analysts

4

Total ratings

n/a

Success rate

-57.72%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Sara Nik

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MBRX Moleculin Biotech	Maintains: Buy	$4 → $22	$2.39	+820.50%	3	Dec 11, 2025
	KTTA Pasithea Therapeutics	Initiates: Buy	$3	$0.88	+240.29%	1	Dec 8, 2025

Moleculin Biotech

Dec 11, 2025

Maintains: Buy

Price Target: $4 → $22

Current: $2.39

Upside: +820.50%

Pasithea Therapeutics

Dec 8, 2025

Initiates: Buy

Price Target: $3

Current: $0.88

Upside: +240.29%